Echeverria claimed she developed terminal ovarian cancer after using J&J's products, like its baby powder, for decades.
After the verdict, J&J released the following statement:
“Ovarian cancer is a devastating diagnosis and we deeply sympathize with the women and families impacted by this disease. We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder. In April, the National Cancer Institute’s Physician Data Query Editorial Board wrote, ‘The weight of evidence does not support an association between perineal talc exposure and an increased risk of ovarian cancer.’ We are preparing for additional trials in the U.S. and we will continue to defend the safety of Johnson’s Baby Powder.” - Carol Goodrich, global media relations, Johnson & Johnson Consumer, Inc.